In animal models of neurodegenerative diseases including AD, neuroprotective and neuroregenerative mechanisms of EPO are related to inhibiting apoptosis, reducing oxidative stress and inflammation, promoting the angiogenesis and neurogenesis, and maintaining blood brain barrier (BBB) integrity [31]. This evidence concerns the gene EPO and Alzheimer disease.